Karen E. Morrison focuses on Genetics, Amyotrophic lateral sclerosis, Genome-wide association study, Gene and Haplotype. Her research investigates the connection between Genetics and topics such as Frontotemporal dementia that intersect with issues in Frameshift mutation. Her Amyotrophic lateral sclerosis study is related to the wider topic of Internal medicine.
Her Genome-wide association study research is multidisciplinary, incorporating elements of LRRK2, Locus and Candidate gene. Karen E. Morrison has included themes like Molecular biology, Annexin and Disease in her Gene study. Her studies in Haplotype integrate themes in fields like C9orf72, Trinucleotide repeat expansion, TARDBP, Allele frequency and Age of onset.
The scientist’s investigation covers issues in Genetics, Amyotrophic lateral sclerosis, Disease, Gene and Internal medicine. Her is involved in several facets of Genetics study, as is seen by her studies on Genome-wide association study, Locus, Single-nucleotide polymorphism, Genetic association and Exon. Her work deals with themes such as Haplotype and Age of onset, which intersect with Single-nucleotide polymorphism.
Amyotrophic lateral sclerosis is a subfield of Pathology that Karen E. Morrison explores. Her work focuses on many connections between Disease and other disciplines, such as Bioinformatics, that overlap with her field of interest in Dementia and Genetic testing. Her Internal medicine research focuses on subjects like Oncology, which are linked to Cohort.
Karen E. Morrison mostly deals with Amyotrophic lateral sclerosis, Genetics, Disease, Genome-wide association study and Gene. Her study in Amyotrophic lateral sclerosis is interdisciplinary in nature, drawing from both Mutation, Genetic variation and Case-control study. Genetics is frequently linked to Parkinson's disease in her study.
Her research integrates issues of Genetic architecture, Locus and Heritability in her study of Genome-wide association study. Karen E. Morrison works mostly in the field of Locus, limiting it down to concerns involving Frontotemporal dementia and, occasionally, Genetic linkage. Her Gene research is multidisciplinary, incorporating perspectives in Protein aggregation and SOD1.
Her primary areas of study are Amyotrophic lateral sclerosis, Genetics, Genome-wide association study, Gene and Locus. Her study on Amyotrophic lateral sclerosis is covered under Internal medicine. Her Genetics study focuses mostly on Single-nucleotide polymorphism, HEK 293 cells, Kinase, Candidate gene and Exome sequencing.
Her Genome-wide association study research includes themes of Genetic predisposition, Project MinE, Minor allele frequency, Allele frequency and Genetic variation. The concepts of her Locus study are interwoven with issues in Frontotemporal dementia, Genetic association, Genotype, Imputation and Computational biology. The study incorporates disciplines such as Genetic linkage and Bioinformatics in addition to Frontotemporal dementia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study
Elisa Majounie;Alan E. Renton;Kin Mok;Elise G. P. Dopper;Elise G. P. Dopper.
Lancet Neurology (2012)
EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) : revised report of an EFNS task force
Peter M. Andersen;Sharon Abrahams;Gian D. Borasio;Mamede de Carvalho.
European Journal of Neurology (2012)
VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death
Diether Lambrechts;Erik Storkebaum;Masafumi Morimoto;Jurgen Del-Favero.
Nature Genetics (2003)
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis
Matthew J Greenway;Peter M Andersen;Carsten Russ;Sean Ennis.
Nature Genetics (2006)
ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)
N. Parkinson;P. G. Ince;M. O. Smith;R. Highley.
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
Wouter van Rheenen;Aleksey Shatunov;Annelot M. Dekker;Russell L. McLaughlin.
Nature Genetics (2016)
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.
Aude Nicolas;Kevin P. Kenna;Alan E. Renton;Alan E. Renton;Nicola Ticozzi.
A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease
V. Plagnol;M.A. Nalls;J.M. Bras;D.G. Hernandez;D.G. Hernandez.
PLOS Genetics (2011)
Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease
A. Beilina;I. N. Rudenko;A. Kaganovich;L. Civiero.
Proceedings of the National Academy of Sciences of the United States of America (2014)
Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS.
B N Smith;N Ticozzi;C Fallini;A S Gkazi.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: